CLSI M Quality Control for Commercial Microbial Identification Systems; Approved Guideline. Final document was approved through the CLSI voting process. – Publication of CLSI M Quality Control for. Commercial Microbial. Buy CLSI M50 A Ed. 1 () Quality Control For Commercial Microbial Identification Systems from SAI Global.
|Published (Last):||8 August 2010|
|PDF File Size:||16.67 Mb|
|ePub File Size:||15.59 Mb|
|Price:||Free* [*Free Regsitration Required]|
Arch Pathol Lab Med Partially in response to public furor over deaths attributed to false-negative Pap smear readings, Congress passed the Clinical Laboratory Improvement Act of The streamlined QC approach was developed following an evaluation of clsj provided by the American Society for Microbiology for a survey conducted to determine the QC failure rates of commercial MISs.
Individualized Quality Control Plan (IQCP): Is It Value-Added for Clinical Microbiology?
Journal List J Clin Microbiol v. You can download and open this file to your own computer but DRM prevents opening this file on another computer, including a networked server. The most recent survey, inevaluated overlots of over 32 million pieces of media.
US Statutes at Large You may delete a document from your Alert Profile at any time. National Center for Biotechnology InformationU. Performance standards for antimicrobial susceptibility testing; 25th informational supplement. This article has been cited by other articles in PMC. The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.
These data are critical to help clinical microbiologists understand the value in IQCP and to further motivate us to allocate resources to this time-consuming effort. CLIA ’88 2 set forth new regulations for personnel standards, specimen management, QC, PT, and quality assurance QA for all entities performing laboratory testing and mandated that testing must follow manufacturers’ recommendations. Due to the refinement and advancement of MIS, this requirement has become difficult and costly for clinical microbiology laboratories and has not been shown to prevent errors when testing patients’ isolates.
Quality control for commercial microbial identification systems. Notes The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM. Please first verify your email before subscribing to alerts.
However, there were concerns expressed by some in industry and in laboratories, as well as by other experts, about the rigidity and the limit of scope with EQC. IQCP will soon be the law of the land for clinical microbiology laboratories; time will tell if it improves our ability to decrease adverse patient outcomes.
Most clinical microbiology laboratories in the United States have access to CLSI documents, and the continuation of their use should be a stand-alone option for microbiology laboratories. Facebook Twitter Email Syndicate.
Clinical Laboratory Improvement Advisory Committee (CLIAC) | DLS |CDC
Sharpa Melissa B. However, it is unlikely that the development of an IQCP for these tests will discover that additional QC will lead to improved patient care.
For decades, the QC recommendations in the CLSI documents have effectively identified problems in clinical microbiology testing systems for which they are designed. On 2 SeptemberASM’s Committee on Laboratory Practices wrote a letter to Andrew Slavitt, Acting Administrator for CMS, stating m50- we as clinical scientists rely on published literature, statistically derived data, and evidence-based medicine to guide our practice http: We have no amendments or corrections for this standard.
MA includes guidelines that may be followed when using an MIS of proven reliability to take a modified QC approach, rather than meeting requirements included in the Clinical Laboratory Improvement Amendments of regulations. These two options would apply to all nonwaived tests and would become effective on 1 January These data showed that the failure rate due to the MIS itself was less than 0.
In addition, laboratories may identify additional risk factors to consider and are not limited to these five components. Please first m5-a in with a verified email before subscribing to alerts.
Add to Alert PDF. Registration is now closed.
CLSI MA – Quality Control for Commercial Microbial Identification Systems; Approved Guideline
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard10th ed CLSI document MA Stakeholders expressed cls at this meeting that manufacturers did not provide laboratories with sufficient information regarding QC and that a clsk requirement for QC would not work with all new technologies.
EQC was designed to minimize the frequency of external QC that was required to control laboratory test systems, help reduce costs and resources for laboratories, and acknowledge technological advances.
Quality control for commercially prepared microbiological culture media; approved standard3rd ed CLSI document MA3. For laboratories accredited by the College of American Pathologists CAPit should be noted that the most recent version of the CAP checklist will require testing of an external control every 31 days 5. The clinical and anatomic pathology laboratory specialties represented include microbiology, immunology, chemistry, hematology, immunohematology, cytopathology, histopathology, genetic testing, and informatics.
Statutes at Large 81 Proceed to Checkout Continue Shopping. US Statutes at Large 81 This standard is also available to be included in Standards Subscriptions.